Skip to content
SNU-449
Tissue
Liver
Disease
Adult hepatocellular carcinoma
Synonyms
SNU449, NCI-SNU-449

Documents

SNU-449

Cell line · Product number 305429

SNU-449 is a human hepatocellular carcinoma (HCC) cell line widely used in research to study liver cancer biology, drug resistance, apoptosis, and novel t...

US$550.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

SNU-449 is a human hepatocellular carcinoma (HCC) cell line widely used in research to study liver cancer biology, drug resistance, apoptosis, and novel therapeutic strategies. As hepatocellular carcinoma is one of the most aggressive and common liver malignancies with poor prognosis, cell lines like SNU-449 are critical for understanding the molecular mechanisms underlying cancer progression and drug responses.

SNU-449 has been particularly useful in studies involving apoptosis and ferroptosis, a regulated form of cell death associated with iron-dependent lipid peroxidation. For example, research has shown that agents like sorafenib, a standard treatment for advanced HCC, and artesunate synergize to induce ferroptosis in SNU-449 cells. This combination exacerbates lipid peroxidation and oxidative stress, leading to extensive cancer cell death. This synergy occurs because artesunate promotes lysosomal ferritin degradation (ferritinophagy), which increases free iron availability, while sorafenib impairs mitochondrial function and depletes glutathione, a critical antioxidant.

SNU-449 has also been used to explore apoptotic pathways in liver cancer. For example, genistein, a natural isoflavone, induces apoptosis in SNU-449 cells by down-regulating thioredoxin-1 (Trx1), an antioxidant protein that regulates reactive oxygen species (ROS) and inhibits apoptosis. Genistein treatment increases ROS levels and activates apoptosis-related pathways, including caspase-3 activation and DNA fragmentation. These findings highlight SNU-449 as a valuable model for studying both apoptosis and ferroptosis, aiding in the development of targeted therapies for hepatocellular carcinoma.

Tissue
Liver
Disease
Adult hepatocellular carcinoma
Synonyms
  • SNU449
  • NCI-SNU-449

02Classification

Organism
Human
Sex
Male
Growth properties
Adherent
Biosafety level
2

03Characteristics

Morphology
Epithelial-like

04Identifiers

Citation
SNU-449 (Cytion catalog number 305429)
NCBI TaxID
9606
Cellosaurus
CVCL_0454

05Expression and susceptibility

Mutational profile
Mutation: ARID1A, p.Glu2250Argfs*28 (c.6747dupA); Mutation: AXIN1, p.Arg712Ter (c.2134C>T), homozygous; Mutation: TP53, p.Lys139Arg (c.416A>G); Mutation: TP53, p.Ala161Thr (c.481G>A), homozygous
Viruses
HBV

06Handling and culture

Culture medium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% heat-inactivated FBS, add 2.5 g/L glucose and 25 mM HEPES
Dissociation reagent
Accutase
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
52 years
Ethnicity
Korean